Lenti-CMV-PRB
(Plasmid
#206165)
-
PurposepMVP Gateway destination vector (3rd generation lentiviral vector) containing human full length PRB gene
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 206165 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti6.3/PL/V5-DEST
- Backbone size w/o insert (bp) 8131
- Total vector size (bp) 11749
-
Modifications to backboneAdded full length PGR gene
-
Vector typeLentiviral ; pMVP Gateway Destination Vector
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameProgesteron receptor B
-
Alt namePRB, PGR
-
SpeciesH. sapiens (human)
-
Insert Size (bp)5241
-
GenBank IDNM_000926.4
-
Entrez GenePGR (a.k.a. NR3C3, PR)
- Promoter CMV
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer CMV-F
- 3′ sequencing primer hGH-PA-R (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byPGR gene is cloned from Addgene plasmid: #89130 Addgene plasmid #206164 was used during gateway cloning.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Lenti-CMV-PRB was a gift from Renee van Amerongen (Addgene plasmid # 206165 ; http://n2t.net/addgene:206165 ; RRID:Addgene_206165) -
For your References section:
A molecular toolbox to study progesterone receptor signaling. Aarts MT, Wagner M, van der Wal T, van Boxtel AL, van Amerongen R. J Mammary Gland Biol Neoplasia. 2023 Nov 29;28(1):24. doi: 10.1007/s10911-023-09550-0. 10.1007/s10911-023-09550-0 PubMed 38019315